Site Search
Professionals 210 results
Capabilities 57 results
Practice Area
Today’s dynamic commercial real estate market calls for attorneys who bring a broad platform of skills and experience to the table. Our real estate practice offers institutional knowledge across an extensive array of real estate transactions.
Practice Area
Our REIT attorneys are experienced in the planning and implementation of a variety of organizational and real estate ownership structures used for REIT formations and transactions. We understand the complex requirements of asset ownership and character of income that must be met to qualify for pass-through tax treatment under the Internal Revenue Code. Our team has extensive experience with IPOs, private placement of debt, securitization of debt, public/private preferred and common equity offerings, PIPE transactions, recapitalizations, trust preferred securities, asset purchase and dispositions, §1031 exchanges, and mergers and acquisitions. Our experience in capital raising (via public and private securities offerings), securitization, and structured finance transactions is just as deep.
Practice Area
Bankruptcy Litigation & Investigations
Large corporate bankruptcies and companies in financial distress often spawn a complex web of claims by lenders, trustees, debtors, creditors, creditors’ committees, investors, shareholders, and other constituents. Attorneys in Winston & Strawn’s complex commercial litigation group and special situations and restructuring group serve as trusted advisors and resolute advocates to protect clients’ business interests and assets in multifaceted Chapter 11 cases and bankruptcy-related disputes.
Experience 70 results
Experience
|July 24, 2025
Winston & Strawn LLP represented Linkhome Holdings Inc., a leading AI-powered U.S. real estate platform, in connection with its upsized $6 million initial public offering. The offering consisted of 1,500,000 shares of common stock priced at $4.00 per share, and the shares are expected to begin trading on the Nasdaq Capital Market under the ticker “LHAI” on July 24, 2025.
Experience
|April 29, 2025
Stream Realty Completes Ownership Transfer of Houston Center
Winston & Strawn represented Stream Realty Partners in connection with the strategic recapitalization of Houston Center, a premier 4.6 million-square-foot Class A office campus in downtown Houston. Through a joint venture with AustralianSuper, one of the world's largest pension funds, Stream Realty Partners has ushered in a new era for this iconic mixed-use development, comprising four buildings. Stream's Value Preservation Advisors (VPA) team will oversee asset management, leasing, property management, and construction management for the campus. This transaction underscores Winston & Strawn's commitment to delivering comprehensive legal solutions in complex real estate and joint venture transactions.
Experience
|April 23, 2025
Voyager Acquisition Corp. and VERAXA Biotech Announce Business Combination
Winston & Strawn represented Voyager Acquisition Corp. in its announced business combination agreement with VERAXA Biotech AG, a biopharmaceutical company developing next-generation antibody-based cancer therapies. The combination will result in VERAXA becoming a publicly traded company on Nasdaq under the ticker symbol “VERX”, with a pre-money equity valuation of $1.3 billion and up to $253 million in cash held in trust by Voyager. The transaction is expected to close in the fourth quarter of 2025, subject to regulatory and shareholder approvals.
Insights & News 627 results
Sponsorship
|December 8, 2025
Winston & Strawn Sponsors REITworld 2025 Annual Conference
Winston & Strawn was proud to sponsor the REITworld Annual Conference. The conference connects more than 1,000 REIT executives and investors to discuss company performance and investment opportunities for the year ahead.
Tax Impacts
|December 4, 2025
|3 Min Read
On December 1, 2025, the U.S. House of Representatives passed two significant pieces of bipartisan legislation aimed at reforming tax administration and judicial review: the Fair and Accountable IRS Reviews (FAIR) Act (H.R. 5346) and the Tax Court Improvement Act (H.R. 5349).
Press Release
|November 24, 2025
|5 Min Read
Winston & Strawn Names 18 New Partners Globally
Chicago – November 24, 2025 – Winston & Strawn LLP is pleased to announce that 18 of the firm’s lawyers have been elevated to partner.
Other Results 31 results
Law Glossary
What Statutes and Regulations Govern the Approval and Marketing of Biosimilars?
Congress passed the Biologics Price Competition and Innovation Act of 2009 (BPCIA) in 2010 an amendment of the Public Health Services Act. The BPCIA is codified at 42 U.S.C. § 262.
Law Glossary
What Exclusivity Periods Are Associated with Biosimilars?
An applicant may not submit an aBLA until four years after the reference product is licensed by the FDA. (See BPCIA § 351(k).) Further, any biosimilar licenses “may not be made effective” until 12 years after the reference product was licensed. (See BPCIA § 351(l).)
Law Glossary
What Is the Difference Between a Biosimilar and a Generic Drug?
A biosimilar is a biologic product that—as the name implies—is similar to its reference product. Because of a biologic’s complexity, it is not possible to synthesize identical biosimilars that are identical copies of their associated reference products.